openPR Logo
Press release

Netherton Syndrome Market is expected to reach US$ 74.31 million by 2027: Lifemax Laboratories, Azitra, Sixera Pharma Ab, Dermelix Biotherapeutics, Matrisys Bioscience, Quoin Pharmaceuticals Ltd

11-13-2020 02:23 PM CET | Health & Medicine

Press release from: The Insight Partners

Netherton Syndrome Market is expected to reach US$ 74.31 million

The Insight Partners market research study of "Netherton Syndrome Market to 2027 – Global Analysis and Forecast by Therapy and Region,". The report highlights trends prevailing in the global Netherton syndrome market, and the drivers and hindrances pertaining to the market growth.

Major Industry Key Players Include Lifemax Laboratories, Inc.; Azitra, Inc.; Sixera Pharma Ab; Dermelix Biotherapeutics; Matrisys Bioscience; Quoin Pharmaceuticals Ltd.; and Krystal Biotech, Inc. are a few of the leading companies operating in the Netherton syndrome market.

Request a sample Report of Netherton Syndrome Market at: https://www.theinsightpartners.com/sample/TIPRE00013771/?utm_source=openpr%2F10291

Netherton syndrome is a rare disorder characterized by trichorrhexis invaginata, atopic diathesis, and ichthyosiform erythroderma. The trichorrhexis invaginata indicates short and brittle hair, atopic diathesis represents susceptibility to allergy problems while ichthyosiform erythroderma encompasses red, inflamed, scaly skin.

Netherton syndrome is hereditary as it is an autosomal recessive trait. The disease is majorly caused due to mutations associated with SPINK5 gene. In some cases, although there is no family history of the disease, the syndrome is revealed even when two healthy parents that carry the mutated recessive gene have a child, which receives both copies of the recessive gene.

Based on therapy, the global Netherton syndrome market is segmented into keratolytic agents, oral and topical steroids and retinoids, topical calcineurin inhibitors, biological therapies, and radiation therapies. In 2019, the keratolytic agents segment held the largest share of the global Netherton syndrome market. However, the biological therapy segment is estimated to register the highest CAGR in the market during the forecast period. The growth of the market for the biological therapy segment is attributed to the increasing adoption of biological therapy due to its beneficial treatment outcomes.

Foundation for Ichthyosis& Related Skin Types (FIRST) in collaboration with National Health Council (NHC) developed an organization that aims to improve lives and seek cures for the patients affected by ichthyosis and related skin types. The organization provides accurate and timely information regarding Netherton syndrome and ichthyosis that helps the patients to meet social, medical and educational needs of the disease community. Furthermore, the Ichthyosis Support Group (ISG) aims to protect and preserve the health and relieves patients affected by ichthyosis and other associated condition. The ISG provides information pack, distributes bulletins and newsletters organize children’s residential camps and others.

Based on therapy, the global Netherton syndrome market is segmented into keratolytic agents, oral and topical steroids and retinoids, topical calcineurin inhibitors, biological therapies, and radiation therapies. In 2019, the keratolytic agents segment held the largest share of the market. Growth of this segmental market is attributed to the increasing product launches and robust existing product pipeline. In addition, strategic activities by service providers such as collaborations, mergers and acquisitions, and expansions to expedite drug timeline are further accelerating the growth of the market. However, the biological therapy segment is projected to register the highest CAGR in the global Netherton syndrome market during 2020–2027.

Product launches and research collaborations are the commonly adopted strategies by companies to expand their footprint worldwide and meet the growing consumer demand. The Netherton syndrome market players adopted the strategy of product innovations to cater to changing customer demand across the world, which also permits them to maintain their brand name globally.

To read more about the report, visit @ https://www.theinsightpartners.com/sample/TIPRE00013771/?utm_source=openpr%2F10291

Contact US:

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686

Email: sales@theinsightpartners.com

ABOUT US:

The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Netherton Syndrome Market is expected to reach US$ 74.31 million by 2027: Lifemax Laboratories, Azitra, Sixera Pharma Ab, Dermelix Biotherapeutics, Matrisys Bioscience, Quoin Pharmaceuticals Ltd here

News-ID: 2187452 • Views: 335

More Releases from The Insight Partners

InGaAs Camera Market 2021 New CAGR To Boom In Near Future By 2027
This research report will give you deep insights about the InGaAs Camera Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the market trends and analysis, competition, industry landscape, market
Surface Protection Tape Market Size 2020 By Product Types, End-Users, Regional O …
"Surface Protection Tape Market: Analysis and Forecast 2020-2027" gives a detailed future prospects of the Surface Protection Tape market. The report highlights the major market events including market players, latest trends, technological advancements and growth opportunities in the Surface Protection Tape market that helps industry experts and investors to take vital business decisions. Additionally, the report focuses on why the interest for Surface Protection Tape is expanding and all
Dual Interface IC Card Market (COVID-19) to Witness Astonishing Growth by Foreca …
The Insight Partners published a new report, titled, “Dual Interface IC Card Market”. The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine steps to be taken to gain a competitive advantage. Dual interface IC card may
Deodorants and Antiperspirant Ingredients Market Overwhelming Hike In Near Futur …
This research report will give you deep insights about the Deodorants and Antiperspirant Ingredients Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the market trends and analysis, competition, industry

All 5 Releases


More Releases for Netherton

Netherton Syndrome Market Top Players- Lifemax Laboratories, Inc.; Azitra, Inc.; …
According to The Insight Partners market research study of "Netherton Syndrome Market to 2027 – Global Analysis and Forecast by Therapy and Region," the global Netherton syndrome market is expected to reach US$ 74.31 million by 2027 from US$ 19.57 million in 2019; it is estimated to grow at a CAGR of 20.3% from 2020 to 2027. The report highlights trends prevailing in the global Netherton syndrome market, and the
Netherton Syndrome Market (Covid-19) Impact and Analysis by 2027 | Lifemax Labor …
The Insight Partners analysts forecasts the latest report on “Netherton Syndrome Market (Covid-19) Impact and Analysis by 2027”, according to report; The Netherton Syndrome Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Netherton Syndrome Market. The study provides details such as the market share,
Beauty Kitchen Support Launch of New App to Test Products for Microplastics
A new app ‘Beat the Microbead’ has been launched by the Plastic Soup Foundation to allow consumers to self-scan products and identify more than 500 types of microplastics. A report from the Ellen MacArthur Foundation, in partnership with the World Economic Forum, predicts that by 2050 plastic in the oceans will outweigh fish. Beat the Microbead, a campaign that Beauty Kitchen continually support, have been pushing for the ban of microbeads